Replies to post #398883 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

That is not even close to what is actually going on at SAVA.

The P3 trial has not even started yet. So there was no release of data in be causing the issue. There was no release on any recent data.

get your facts straight


https://www.cassavasciences.com/news-releases/news-release-details/cassava-sciences-announces-positive-cognition-data-simufilam

Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer’s Disease

Simufilam Significantly Improves Cognition in Patients with Alzheimer’s in Interim Analysis of Open-label Study at 9 Months

[Doc logic]

exwannabe,

What Linda Powers is doing with the control of data release is called self determination. She knows how to use leverage to get what she wants especially with deal making. As PoorMan and others have pointed out, deal making could very well be in the works based on the way NWBO is handling finances and hiring. Why let those with nothing good to say be given the opportunity to downplay partial news? I guess those folks never watched Bambi and the admonition to say nothing at all if nothing good to say could be found. If the present circumstances indicate that NWBO is running out of time and options for financing and debt repayment and they promised an update on manufacturing readiness by the end of September and journal articles might typically take up to 13 months from data lock then we are in a tight window where something significant will be announced. If Linda told suitors to be ready by shortly after the journal article and Merck is being given the first shot then we are about at the end of the previews. Best wishes.